Skip to main content
Account

Table 4 Clinical characteristics, univariate analysis, and multinomial logistic regression analysis based on different longitudinal trajectories of fecal calprotectin levels in patients with ulcerative colitis

From: Impact of early aggressive treatment on long-term biochemical marker patterns in inflammatory bowel disease

 

Total patients

Univariate analyses

Multinomial logistic regression analysis

Class 1

Class 2

Class 3

p-valuea

OR (95% CI)

p-valuea

Class 2b

Class 3b

Number

536

243 (45.3)

42 (7.8)

251 (46.8)

    

Female

198 (36.9)

94 (38.7)

19 (45.2)

85 (33.9)

0.276

   

Age at diagnosis, years

38.7 (14.2)

41.0 (12.8)

35.7 (16.2)

37.0 (15.3)

0.003

0.969

(0.944–0.995)

0.980

(0.966–0.994)

0.004

Current smoker

84 (15.7)

48 (19.8)

2 (4.8)

34 (13.5)

0.021

0.194

(0.044–0.846)

0.559

(0.330–0.945)

0.008

History of appendectomyc

15 (2.8)

10 (4.1)

0 (0)

5 (2.0)

0.187

 

0.420

(0.133–1.325)

0.091

CCI

        

0

443 (82.6)

202 (83.1)

37 (88.1)

204 (81.3)

0.837

   

1

64 (11.9)

29 (11.9)

3 (7.1)

32 (12.7)

   

 ≥ 2

29 (5.4)

12 (4.9)

2 (4.8)

15 (6.0)

   

Positive ANCA titer

51 (9.5)

19 (7.8)

4 (9.5)

28 (11.2)

0.506

   

Elevation of ASCA

IgG or IgA

86 (16.0)

31 (14.0)

8 (20.5)

47 (20.8)

0.154

1.220

(0.501–2.972)

1.384

(0.824–2.325)

0.500

Disease extent

        

Proctitis

210 (39.2)

102 (42.0)

19 (45.2)

89 (35.5)

0.277

   

Left-sided colitis

151 (28.2)

69 (28.4)

13 (31.0)

69 (27.5)

   

Extensive colitis

175 (32.6)

72 (29.6)

10 (23.8)

93 (37.1)

   

Early CS

165 (30.8)

61 (25.1)

15 (35.7)

89 (35.5)

0.034

1.032

(0.470–2.267)

1.030

(0.662–1.604)

 > 0.999

Early IM

36 (14.8)

36 (14.8)

15 (35.7)

80 (31.9)

 < 0.001

2.928

(1.289–6.651)

2.698

(1.657–4.394)

 < 0.001

Early AT

11 (2.1)

3 (1.2)

1 (2.4)

7 (2.8)

0.470

   

Early ER visit

35 (6.5)

14 (5.8)

3 (7.1)

18 (7.2)

0.806

   

Early hospitalization

29 (5.4)

10 (4.1)

2 (4.8)

17 (6.8)

0.419

   
  1. CCI, Charlson comorbidity index; ANCA, anti-neutrophil cytoplasmic antibody; ASCA, anti-Saccharomyces cerevisiae antibody; CS, corticosteroid, IM, immunomodulator; AT, advanced therapy; ER, emergency room
  2. Values are presented as the mean (standard deviation) or number (%)
  3. a p-value is indicated in bold when < 0.200 in univariate analyses and when < 0.050 in multinomial logistic regression analysis
  4. b All groups were compared with class 1
  5. c Classes 1 and 2 could not be compared because no patients in class 2 had a history of appendectomy